Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 GBX | 0.00% | +3.57% | +70.59% |
04-26 | Auckett Swanke shares down as half-year loss widens | AN |
04-26 | AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract | AN |
Sales 2022 | 7.13M 8.94M 713M | Sales 2023 | 14.1M 17.69M 1.41B | Capitalization | 5.03M 6.3M 503M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.51M -200M | Net income 2023 | - 0 0 | EV / Sales 2022 | 0.91 x |
Net Debt 2022 | 2.54M 3.19M 254M | Net Debt 2023 | 4.12M 5.17M 412M | EV / Sales 2023 | 0.65 x |
P/E ratio 2022 |
-1.73
x | P/E ratio 2023 |
44.5
x | Employees | 132 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 26.41% |
1 week | +3.57% | ||
1 month | +16.00% | ||
3 months | +31.82% | ||
6 months | +7.41% | ||
Current year | +70.59% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Clark
CEO | Chief Executive Officer | 49 | 20/04/23 |
Antony Barkwith
DFI | Director of Finance/CFO | 44 | 31/10/18 |
Freddie Jenner
COO | Chief Operating Officer | 40 | 26/06/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Carver
CHM | Chairman | 63 | 09/05/19 |
Robert Fry
BRD | Director/Board Member | 67 | 28/03/18 |
Tandeep Minhas
BRD | Director/Board Member | 53 | 23/04/23 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 1.45 | 0.00% | 11,442 |
02/05/24 | 1.45 | 0.00% | 126 |
01/05/24 | 1.45 | 0.00% | 0 |
30/04/24 | 1.45 | +3.57% | 32,831 |
29/04/24 | 1.4 | 0.00% | 121,663 |
Delayed Quote London S.E., May 03, 2024 at 04:35 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+70.59% | 5.33M | |
-11.92% | 3.96B | |
+49.15% | 2.29B | |
+18.64% | 1.95B | |
+26.63% | 1.75B | |
-15.60% | 1.51B | |
+14.84% | 1.16B | |
+14.05% | 986M | |
+40.87% | 933M | |
+28.95% | 905M |
- Stock Market
- Equities
- AUK Stock